About Lee’s PHARM
Lee’s PHARM is a publicly listed company based in Hong Kong (China) founded in 2002. Innovative biopharmaceutical products are developed to address unmet medical needs. The company has 1,020 employees. Its chief executive, as recorded, is Benjamin Li. Lee’s PHARM offers products and services including Pharmaceutical Products and Research and Development Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Lee's Pharmaceutical Holdings Limited.
Company details
The company was founded in 2002 in Hong Kong, China, within the biopharmaceutical sector. Research and development efforts are conducted internally and through collaborations to produce pharmaceutical products. Manufacturing occurs at company-owned facilities. The portfolio encompasses treatments for rare diseases, with participation in industry conferences. Investor relations and drug safety details are provided for stakeholders.
- Headquarters Hong Kong, China
- Employees 1,020
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website leespharm.com
- Social LinkedIn
- Legal Name Lee's Pharmaceutical Holdings Limited
- Annual Revenue$184.99 M (USD)2.57as on Dec 31, 2025
- Net Profit$11.81 M (USD)-1.25as on Dec 31, 2025
- EBITDA$27.89 M (USD)-1.73as on Dec 31, 2025
- Employee Count1,020
Products & Services of Lee’s PHARM
Lee’s PHARM offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Research and Development Services.
Various pharmaceutical products are developed for therapeutic uses, stemming from internal R&D and partnerships
Clinical trials and product pipelines are managed to advance medical frontiers and address unmet needs
People of Lee’s PHARM
10 people are tracked at Lee’s PHARM (4 in leadership, 6 in board & advisors); the tracked headcount is 1,020.
| Name | Role | Group |
|---|---|---|
Benjamin Li | CEO | Leadership |
Brian L. | Senior Director, Group IT | Leadership |
Wanee Leelalertsuphakun | Chief Executive Officer | Leadership |
Ivan Lee | Director Of Sales And Marketing | Leadership |
Lee Siu Fong | Chairman | Board & advisors |
Lam Yat Cheong | Director | Board & advisors |
Leelalertsuphakun Wanee | Director | Board & advisors |
Tsim Wah Keung | Director | Board & advisors |
Li Xiaoyi | Director | Board & advisors |
Chan Yau Ching | Director | Board & advisors |
Complete people profiles for Lee’s PHARM
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Lee’s PHARM
Lee’s PHARM is a publicly listed company on the HKEX with ticker symbol 950 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jul 2002
- Listed onHKG: 950
- Listed entityLee's Pharmaceutical Holdings Limited
- Exchange sectorHealth technology
- ISINKYG5438W1116
- Share price1.09 HKD (+0.46% on the day) · 2026-10-14
- Market capitalisation638,886,352.00 HKD
- Price to earnings5.4
- EPS (diluted, trailing year)0.20 HKD
- Dividend yield4.33%
- Volume (last session)313,500
Financials of Lee’s PHARM
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.44B HKD | 91.9M HKD | 217.1M HKD |
| 2024 | 1.40B HKD | 93.1M HKD | 221.0M HKD |
| 2023 | 1.05B HKD | 16.7M HKD | 109.8M HKD |
| 2022 | 1.23B HKD | 51.3M HKD | 209.8M HKD |
| 2021 | 1.27B HKD | 1.99B HKD | -44.7M HKD |
Detailed financial statements for Lee’s PHARM
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Lee’s PHARM
Websites that share an audience with Lee’s PHARM (leespharm.com).
- Global rank#12,343,912
among all websites
- Category rank#8,256
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit1.7
- Average visit41 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with Lee’s PHARM. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neuroderm.com | 100% | 2.8K | #5,643,423 | View details | |
dolbyresearch.com | dolbyresearch.com | 99% | – | ||
| vblrx.com | 99% | 2.5K | #3,978,257 | View details | |
| cel-sci.com | 99% | 3.2K | #5,603,385 | View details | |
| ichorms.com | 98% | 5.3K | #8,265,520 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Lee’s PHARM
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lee’S Pharm
Complete news archive for Lees PHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lee’s PHARM
Lee’s PHARM was founded in 2002.
Lee’s PHARM is headquartered in Hong Kong, China.
Benjamin Li is the CEO of Lee’s PHARM, as recorded in our data.
Lee’s PHARM has 1,020 employees.
Annual revenue of Lee’s PHARM is $184.99M as on Dec 31, 2025.
The company was founded in 2002 in Hong Kong, China, within the biopharmaceutical sector. Research and development efforts are conducted internally and through collaborations to produce pharmaceutical products. Manufacturing occurs at company-owned facilities. The portfolio encompasses treatments for rare diseases, with participation in industry conferences. Investor relations and drug safety details are provided for stakeholders.
Lee’s PHARM offers Pharmaceutical Products and Research and Development Services.
Yes, Lee’s PHARM is publicly traded on HKEX under the ticker symbol 950.
Lee’s PHARM operates through Lee's Pharmaceutical Holdings Limited.